Anqi Q. Yu

Beijing, 100871, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Comparative Interactome Profiling of Itaconate and α-Ketoglutarate by the Peptide-Centric Local Stability Assay.

Comparative Interactome Profiling of Itaconate and α-Ketoglutarate by the Peptide-Centric Local Stability Assay.

Journal: ACS chemical biology

Published: June 13, 2026

Chemoproteomics identifies STAT3 as a key target of baicalin in ameliorating liver fibrosis.

Chemoproteomics identifies STAT3 as a key target of baicalin in ameliorating liver fibrosis.

Journal: National science review

Published: September 16, 2025

Thermal proteome profiling of itaconate interactome in macrophages.

Thermal proteome profiling of itaconate interactome in macrophages.

Journal: Chemical science

Published: March 29, 2025

Expedited program and utilization for anticancer drug approval in China and the United States

Expedited program and utilization for anticancer drug approval in China and the United States

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: September 18, 2024

Geriatric drug trials on solid tumor are scarce worldwide.

Geriatric drug trials on solid tumor are scarce worldwide.

Journal: Frontiers in medicine

Published: October 07, 2022

The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges.

The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges.

Journal: The Lancet regional health. Western Pacific

Published: August 01, 2022

Targeting rare tumors: new focus for clinical research in China.

Targeting rare tumors: new focus for clinical research in China.

Journal: EMBO molecular medicine

Published: June 07, 2022

Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemia.

Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemia.

Journal: Blood science (Baltimore, Md.)

Published: September 01, 2021

Platform study of genotyping-guided precision medicine for rare solid tumours: a study protocol for a phase II, non-randomised, 18-month, open-label, multiarm, single-centre clinical trial testing the safety and efficacy of multiple Chinese-approved targeted drugs and PD-1 inhibitors in the treatment of metastatic rare tumours.

Platform study of genotyping-guided precision medicine for rare solid tumours: a study protocol for a phase II, non-randomised, 18-month, open-label, multiarm, single-centre clinical trial testing the safety and efficacy of multiple Chinese-approved targeted drugs and PD-1 inhibitors in the treatment of metastatic rare tumours.

Journal: BMJ open

Published: June 04, 2021

The Landscape of Cell and Gene Therapies for Solid Tumors.

The Landscape of Cell and Gene Therapies for Solid Tumors.

Journal: Cancer cell

Published: January 12, 2021

Whole-exome sequencing reveals genetic underpinnings of salivary adenoid cystic carcinoma in the Chinese population.

Whole-exome sequencing reveals genetic underpinnings of salivary adenoid cystic carcinoma in the Chinese population.

Journal: Journal of genetics and genomics = Yi chuan xue bao

Published: April 03, 2020

A review of immune-related adverse events associated with immunotherapy

A review of immune-related adverse events associated with immunotherapy

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: February 07, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026